Pluripotent Stem Cells: From Basic Research to Therapeutic Applications

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 775

Special Issue Editors


E-Mail Website
Guest Editor
Research Group Reproduction and Genetics, Vrije Universiteit Brussel, Brussels, Belgium
Interests: human pluripotent stem cells; genome instability; aneuploidy; differentiation capacity; tumorigenesis
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor Assistant
Research Group Reproduction and Genetics, Vrije Universiteit Brussel, Brussels, Belgium
Interests: human pluripotent stem cells; aneuploidy; organoid; tumorigenesis

Special Issue Information

Dear Colleagues,

Pluripotent stem cells (PSCs) are remarkable cells that can differentiate into any cell of the embryonic lineage, and depending on their state of pluripotency and species, they can also generate extraembryonic cell types. PSCs can be derived from early-stage embryos as embryonic stem cells (ESCs) or from adult somatic cells through reprogramming, creating induced pluripotent stem cells (iPSCs). These cells have revolutionized medical research and clinical applications due to their unique potential for therapy and regenerative medicine. They can be used to repair or replace damaged tissues, potentially overcoming donor scarcity and immune rejection. Up to now, there are over 1,800 ongoing clinical trials worldwide that are testing stem cell therapies across various phases of development, covering a wide range of applications from treating neurological disorders and blindness to regenerative therapies for cardiovascular diseases and beyond. Moreover, PSCs can serve as invaluable tools for studying developmental biology and cellular differentiation, allowing researchers to investigate the mechanisms that regulate cell fate and provide insights into normal development and the underlying causes of various diseases. This Special Issue aims to explore the recent advances in PSC research, covering the molecular mechanisms of pluripotency, genetic modification, tissue engineering, disease modeling, drug discovery, and early-stage clinical trials.

Prof. Dr. Claudia Spits
Guest Editor

Dr. Diana Al Delbany
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pluripotent stem cells
  • embryonic stem cells
  • induced pluripotent stem cells
  • organoids
  • differentiation
  • regenerative medicine
  • disease modeling
  • cell therapy
  • therapeutic applications

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

20 pages, 704 KiB  
Review
Clinical Applications of Corneal Cells Derived from Induced Pluripotent Stem Cells
by Yixin Luan, Aytan Musayeva, Jina Kim, Debbie Le Blon, Bert van den Bogerd, Mor M. Dickman, Vanessa L. S. LaPointe, Sorcha Ni Dhubhghaill and Silke Oellerich
Biomolecules 2025, 15(8), 1139; https://doi.org/10.3390/biom15081139 - 7 Aug 2025
Viewed by 390
Abstract
Corneal diseases are among the leading causes of blindness worldwide and the standard treatment is the transplantation of corneal donor tissue. Treatment for cornea-related visual impairment and blindness is, however, often constrained by the global shortage of suitable donor grafts. To alleviate the [...] Read more.
Corneal diseases are among the leading causes of blindness worldwide and the standard treatment is the transplantation of corneal donor tissue. Treatment for cornea-related visual impairment and blindness is, however, often constrained by the global shortage of suitable donor grafts. To alleviate the shortage of corneal donor tissue, new treatment options have been explored in the last decade. The discovery of induced pluripotent stem cells (iPSCs), which has revolutionized regenerative medicine, offers immense potential for corneal repair and regeneration. Using iPSCs can provide a renewable source for generating various corneal cell types, including corneal epithelial cells, stromal keratocytes, and corneal endothelial cells. To document the recent progress towards the clinical application of iPSC-derived corneal cells, this review summarizes the latest advancements in iPSC-derived corneal cell therapies, ranging from differentiation protocols and preclinical studies to the first clinical trials, and discusses the challenges for successful translation to the clinic. Full article
Show Figures

Figure 1

Back to TopTop